Latest Alzinova News & Updates

See the latest news and media coverage for Alzinova. We track all announcements, press releases, and industry mentions in real time, all in one place.

Alzinova

Clinical-stage biopharma developing Alzheimer's immunotherapy

alzinova.com

Headquarters: Gothenburg, Sweden
Founded year: 2011
Company type: Public company
Number of employees: 5–10
Industry: Pharmaceuticals

Last updated Today

Latest news about Alzinova

In short: Alzinova advanced its Alzheimer's vaccine ALZ-101 toward Phase II trials and secured diagnostic partnerships and capital via warrants.

Company announcements

June 24 Alzinova

Alzinova signs Letter of Intent with Fujirebio

The potential collaboration aims to develop and commercialize a blood-based Alzheimer's diagnostic test using Alzinova's Aβ42CC oligomer technology.

June 12 Alzinova

Alzinova receives SEK 15.3M from 94.2% warrant exercise

The funds will advance ALZ-101 towards Phase II, progress partnership talks, and continue diagnostics development.

June 8 Alzinova

Alzinova announces preliminary outcome of warrant exercise

Subscriptions of 47.6 million shares at SEK 0.32 each yield about SEK 15.2 million. Underwriting not utilized.

June 3 Alzinova

Alzinova announces last trading day for TO4 warrants

The exercise period runs to June 8, 2026, at SEK 0.32 per share. Full exercise would yield about SEK 16.2 million before costs.

Media coverage

May 13 FinanzNachrichten.de

Alzinova AB: Alzinova publishes interim report for the period January - March 2026

The Board of Directors and the Chief Executive Officer of Alzinova AB hereby present the interim report for the period January - March 2026. The...

April 8 360dx

Alzinova, Amsterdam UMC to Develop Blood-Based Alzheimer's Diagnostic Assay

The collaboration aims to develop a blood-based test that measures naturally occurring antibodies against toxic amyloid‑β oligomers in healthy individuals.

March 25 TradingView

Alzinova publishes year-end report 2025 — TradingView News

The Board of Directors and the Chief Executive Officer of Alzinova AB hereby present the year-end report for the period January – December, and the...

March 16 FinanzNachrichten.de

Alzinova AB: Alzinova's Board of Directors resolves on a directed issue of units to underwriters in connection with the completed rights issue

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, AUSTRALIA, JAPAN, NEW ZEALAND, SOUTH...

Never miss news about Alzinova

Track Alzinova and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.

Alzinova competitors & trending companies

Browse news for competitors to Alzinova and other trending companies.